Drug users from Kachin came together last November to discuss the challenges and difficulties they experience and identify possible solutions to their problems. Read their statement and recommendations.
The UN General Assembly Special Session (UNGASS) on drugs – held in New York in April 2016 – was hailed as an opportunity for the international community ‘to conduct a wide-ranging and open debate that considers all options’. Although the UNGASS was characterised by many shortcomings and disappointments, it was nonetheless a critical moment for global drug policy reform.
The voices of affected communities involved in the cultivation of coca leaf, opium poppy and cannabis plants are lacking in the global debate on drug policy reform in general and were at risk of being excluded from the United Nations General Assembly Special Session (UNGASS) 2016 on The World Drug Problem.
To address its serious drug use problems, Myanmar should change its drug policy towards a harm reduction approach. Instead of a repressive approach, voluntary and evidence-based treatment and public health services, including harm reduction, should be made available and become generally accepted by enforcement officials and by the community at large.
Paraguay is the principal producer of cannabis in South America. Despite its importance as a supplier of cannabis in South America, there has been a surprising absence of serious studies of its impact on its own society, and on the play of offer and demand in neighbouring countries.
Civil society groups from across the globe, including prominent human rights NGOs, have called on UN drug control authorities to urge an immediate stop to the extrajudicial killings of suspected drug offenders in the Philippines. Since 10th May 2016, more than 700 people have been killed by police and vigilantes in the Philippines for being suspected of using or dealing drugs, as a direct result of recently-elected President Duterte’s campaign to eradicate crime within six months.
A special session of the General Assembly took place in April revealing a growing divergence in the global drug policy landscape. Difficult negotiations resulted in a disappointing outcome document, perpetuating a siloed approach to drugs at the UN level. There is a clear need to realign international drug policies with the overarching 2030 Agenda and the Sustainable Development Goals, embedding the drugs issue comprehensively within the UN’s three pillars: development, human rights, and peace and security. The UNGASS process has helped to set the stage for more substantial changes in the near future, towards the next UN review in 2019.
As an increasing number of jurisdictions consider whether and how to legalize and regulate access to cannabis, tensions are growing between these initiatives and countries’ obligations under the UN drug control conventions. A groundbreaking new report produced by a coalition of legal and drug policy experts offers strategies for countries exploring regulatory approaches to cannabis to do so in ways that ensure that their domestic reforms align with their international legal obligations.
Alors que des législatures adoptent des réformes établissant l’accès légal au cannabis pour des fins autres qu’exclusivement « médicales et scientifiques », les tensions entourant les traités actuels des Nations Unies en matière de drogues et l’évolution des lois et pratiques des États membres continuent de s’intensifier. Comment les gouvernements et les systèmes onusiens pourraient-ils aborder ces tensions croissantes par des moyens qui reconnaissent les changements de politiques en cours et qui aident à moderniser le régime des traités sur les drogues, à proprement parler, et par le fait même à renforcer les piliers onusiens des droits humains, du développement, de la paix et de la sécurité ainsi que de la primauté du droit?
Opium farmers and representatives of their communities came together to discuss the challenges they face in their lives, and to share experiences and find ways to solve their problems. This is their statement.
With an increasing number of jurisdictions enacting or contemplating reforms creating legal access to cannabis for purposes other than exclusively "medical and scientific," tensions regarding the drug conventions and evolving law and practice in Member States continue to grow.